Skip to main content

Peer Review reports

From: Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment

Original Submission
2 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
6 Apr 2021 Reviewed Reviewer Report
8 Apr 2021 Reviewed Reviewer Report
25 Apr 2021 Reviewed Reviewer Report
3 Jun 2021 Author responded Author comments - Lin Zhang
Resubmission - Version 6
3 Jun 2021 Submitted Manuscript version 6
28 Jul 2021 Reviewed Reviewer Report
31 Jul 2021 Reviewed Reviewer Report
23 Aug 2021 Author responded Author comments - Lin Zhang
Resubmission - Version 7
23 Aug 2021 Submitted Manuscript version 7
27 Oct 2021 Reviewed Reviewer Report
27 Nov 2021 Author responded Author comments - Lin Zhang
Resubmission - Version 8
27 Nov 2021 Submitted Manuscript version 8
30 Nov 2021 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
8 Dec 2021 Editorially accepted
28 Dec 2021 Article published 10.1186/s12872-021-02414-7

You can find further information about peer review here.

Back to article page